Published Jan 1, 2020
#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
Explore the evolving landscape of cardiovascular treatments with Peter Attia and Thomas Dayspring as they dive deep into the efficacy and controversies of niacin, fibrates, and statins, discussing their impacts, clinical trials, and the future of personalized therapy.
